ISS on its own Stimulates Dynavax and AstraZeneca to collaborate on Asthma
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 76 (Table of Contents)
Published: 6 Oct-2006
DOI: 10.3833/pdr.v2006.i76.442 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Dynavax Technologies entered into research collaboration and license agreement with AstraZeneca to discover and develop toll-like receptor (TLR)-9 agonist-based therapies for treating asthma and chronic and obstructive pulmonary disease (COPD)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS